PACE Announces £6 Million Funding for Antibacterial Treatment Innovations to Fill Critical Gap in R&D Pipeline
PACE (Pathways to Antimicrobial Clinical Efficacy) launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health.